TY  - CONF

T1  - Improvements in health-related quality of life measured by SF-36 and EQ-5D in patients with moderate to severe plaque psoriasis treated with brodalumab

JO  - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PY  - 2016/05/01

AU  - Paul C

AU  - Barker J

AU  - Klekotka P

AU  - Milmont C

AU  - Viswanathan H

AU  - Nirula A

AU  - Brazier J

AU  - Harrison D

AU  - Mutebi A

AU  - Kricorian G

ED  - 

VL  - 74

IS  - 5

SP  - AB256

EP  - AB256

Y2  - 2024/12/26

ER  -